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Background: Suicidal thoughts are common in the general population, causing significant disability. However, a
substantial number of people struggling with suicidality do not access appropriate services. Online self-help may
help overcome barriers to help-seeking. This study aims to examine the effectiveness of an online self-help program
targeted at reducing suicidal thoughts compared with an attention-matched control condition in the Australian
adult population. This trial is based on a Dutch self-help program, which was found to be effective in reducing
suicidal thoughts.
Methods/Design: A total of 570 community-dwelling adults (18 to 65 years old) with suicidal thoughts will be
recruited via various media and randomly assigned to the 6-week online program aimed at reducing suicidal
thoughts or a 6-week attention-matched control program. Primary outcome measure is the severity of suicidal
thoughts. Secondary outcome measures include suicide plans, capacity to cope with suicidal thoughts, reasons for
living, symptoms of depression, hopelessness, anxiety/worry, rumination, panic, perceived burdensomeness and
thwarted belongingness, acquired capability, alcohol consumption, insomnia, and various cost-effectiveness measures.
Discussion: Although the original Dutch trial found web-based self-help to be effective in reducing suicidal thoughts,
randomized controlled trials (RCT) of online programs for suicidal thoughts are rare. The present study extends previous
research by running the first English language RCT of this sort. As a result of the original study, the current RCT includes
refinements to the design, including greater levels of participant anonymity and longer follow-up periods. Limitations
of this trial include the potential for high drop-out and the inability to ascertain whether any suicides occur during
the study.
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Suicidal thoughts are common in the general population.
A cross-national study of 17 countries reported an aver-
age lifetime prevalence of 9.2% for suicidal thoughts,
3.1% for plans, and 2.7% for attempts. However, there
was considerable variability in prevalence rates between
the countries [1]. In Australia, an estimated 13.3% of
adults experience suicidal thoughts at some stage in
their lives, 4.0% make a suicide plan, and approximately
3.2% of adults attempt suicide [2].
A significant proportion of people with suicidal
thoughts or plans do not use services for mental health
problems (in Australia, 40.9% and 32.0% respectively).
In people who attempt suicide, about one in four
(26.6%) fail to access services [2]. In a worldwide sur-
vey, it was found that 44% of people experiencing any
suicidal outcome in high income countries do not re-
ceive treatment [3], indicating that current services do
not reach everyone in need.
Reasons for a failure to seek help among suicidal
people are diverse and likely to be complex. However,
factors that may play a role include fear of stigma,
shame, dissatisfaction or past negative experiences with
mental health services, preference for self-reliance (hand-
ling the problem alone), denying the severity of the
problem, and financial constraints [3-6].
It is widely acknowledged that suicide prevention ser-
vices that are anonymous, confidential and readily avail-
able appeal to those at risk. Illustrative of this is the
worldwide use of telephone support services. Although
these are generally perceived as a valuable suicide preven-
tion strategy, evidence for their effectiveness is limited and
equivocal [7]. The internet is also increasingly being used
as a source of information and of help and support for sui-
cidal people and their loved ones, as demonstrated by the
availability of peer-to-peer support forums, e-mail and
chat therapy services, crisis chat services, and self-tests
with advice and referrals [8-11]. Reviews of empirical
studies into online suicide prevention efforts show that
this is an emergent but promising field [12-14].
There is also recent evidence that web-based programs
are associated with a reduction of suicidal thoughts. An
uncontrolled study into web-based Cognitive Behavior
Therapy (CBT) for depression found that suicidal idea-
tion decreased post-treatment [15]. A randomized con-
trolled (RCT) trial into online CBT for depression found
reductions in suicidal thoughts irrespective of group al-
location [16]. Both these earlier trials were of depression
interventions. A Dutch trial studying an online unguided
self-help program aimed specifically at reducing suicidal
thoughts found this program to be effective compared to
a control condition receiving psycho education [17,18].
To permit further and broader investigation, the Dutch
program has now been translated into English.This paper describes the protocol of the ‘Healthy
Thinking’ trial, which aims to include 570 community
dwelling adults living in Australia. Participants will be
randomly allocated to one of the following conditions:
‘Living with Deadly Thoughts’ (LWDT) - the web-based
self-help program aimed at helping people reduce sui-
cidal thoughts, or ‘Living Well’ - an attention-matched
control condition. This trial is based on the previous
Dutch trial [19], but was adapted to the Australian con-
text and improved. Limitations of the Dutch trial in-
cluded the use of a waitlisted psycho-education control
group, introducing unequal amounts of material pre-
sented to each group as a potential confound. The
current trial utilizes an attention-matched comparator
condition to account for this. In addition, participants in
the Dutch trial were not anonymous, which may have
impacted sample representativeness due to (un)willing-
ness to participate. The current trial therefore offers
anonymity as an option. Safety procedures developed
specifically for the trial will operate while still permitting
anonymous participation. These are documented here.
Finally, the current trial employs a longer follow-up
period to gauge longer-term maintenance of effects, and
the look and feel of the program website has been im-
proved to enhance user experience.
The primary objective of this parallel group RCT is to de-
termine whether the Living with Deadly Thoughts program
is superior to the Living Well program. It is hypothesized
that participants receiving the LWDT program will have
lower levels of suicidal thoughts on the Columbia-Suicide Se-
verity Rating Scale (C-SSRS) relative to the control condition
at post-test (6 weeks). The relative advantage of the active
program compared to the control program is expected to be
maintained at 6 and 12 month follow-up.
The key secondary outcomes include suicide plans,
capacity to cope with suicidal thoughts, reasons for liv-
ing, symptoms of depression, hopelessness, anxiety/
worry, rumination, panic, perceived burdensomeness
and thwarted belongingness, acquired capability, alco-
hol consumption, insomnia, help-seeking intentions
and health care utilization. Relative to the control con-
dition, LWDT participants are expected to 1) show a
reduction of self-reported suicide plans at post-test and
at 6 and 12 month follow-up; 2) show an improvement
of capacity to cope with suicidal thoughts at post-test
and 6 and 12 months; 3) experience an increase in ‘rea-
sons for living’ at post-test, 6 and 12 months; 4) have
lower symptoms of depression, hopelessness, anxiety/
worry, rumination, panic, perceived burdensomeness,
thwarted belongingness, and disability at post-test, 6
and 12 months; and 5) demonstrate an increase in
help-seeking intentions and utilization of primary and
mental health care at 6 and 12 months (but not neces-
sarily in hospitalization).
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suicidality (as measured by suicidal ideation, suicide
plans and capacity to cope with suicide thoughts) are
hypothesized to be associated with reduction of anxiety
and depressive symptoms; a history of fewer self-
reported attempts; shorter history of suicidal thinking;
reduction in rumination; and improvement in perceived
burdensomeness and thwarted belongingness. Improve-
ment in suicidality is not expected to be related to
changes in capability to attempt suicide, as per Joiner’s
Interpersonal Theory of Suicide [20]. Stronger adherence
to the program at 6 weeks is expected to be associated
with lower baseline levels of hopelessness and higher
baseline levels of internet literacy. Trial dropout at post-
test, 6 and 12 months is hypothesized to be associated
with higher baseline levels of hopelessness in both
groups [18]. Other factors associated with adherence
and drop-out will be explored.
Methods/Design
Design
This study is designed as a two-arm randomized con-
trolled trial with one active program (‘Living with Deadly
Thoughts’) and one control program (‘Living Well’). There
will be five main measurement occasions: screening, base-
line, post-test (6 weeks after baseline), and two follow-up
measures (6 and 12 months after post-test). In addition,
suicidal thoughts will be monitored on a fortnightly basis
during the first six weeks after randomization (that is,
while the active group goes through the active program)
to inform safety procedures (see below). The trial flow is
illustrated in Figure 1. Participants who stop using the
program they are assigned to will still be sent all follow-up
questionnaires to complete (unless they have requested to
be withdrawn from the study).
We adhere to the SPIRIT guidelines in reporting the
trial in this protocol (see Table 1 for the items from the
World Health Organization Trial Registration Data Set)
[21,22].
Sample and recruitment
A total of 570 Australian community dwelling adults ex-
periencing suicidal thoughts will be recruited through
various online and offline media, relevant websites,
popular social networking sites and advertising on popu-
lar search engines. Through these advertisements, re-
spondents are linked to a welcome screen where a brief
introduction to the study is provided. Next, respondents
will be invited to provide informed consent to complete
the online screening procedure to verify eligibility.
Eligibility and screening
Eligibility is based on 1) being aged between 18 and 65, 2)
having a valid email address, 3) having a reliable internetconnection, 4) currently being located in Australia, 5)
being fluent in English, 6) never having been diagnosed
with a psychotic disorder such as schizophrenia, 7) cur-
rently experiencing suicidal thoughts, and 8) not having
attempted suicide in the past month.
During screening, respondents indicate their eligibility
by answering questions about the above criteria. Ineligi-
bility during the screening process results in redirection
to a ‘thank you’ page with relevant referral information.
Respondents who are excluded based on a recent suicide
attempt (past month) are also provided with the oppor-
tunity to submit their phone number to receive a phone
call from the Suicide Call Back Service (SCBS: a 24-
hour, Australia-wide, not-for-profit service that provides
telephone counseling to people who are suicidal).
All eligible respondents are provided with a participant
information statement, which outlines that participation
includes agreeing to make contact with the SCBS and
completing the baseline questionnaire before being ran-
domly allocated to one of the two programs. Making ini-
tial contact with the SCBS is needed as this organization
plays a significant role in the safety procedures (de-
scribed in more detail below). After having read the par-
ticipant information statement (see Additional file 1),
respondents will be invited to provide informed consent
online (see Additional file 2) and will need to provide
only a valid email address and a first name to register
their participation. They are also given the option to
submit their phone number while consenting, which can
then be used in the safety procedures if needed, but this
is not mandatory for participation. This way, participants
can remain anonymous if desired. See also Figure 1 for
the trial flow-chart. Participants only enter the trial after
they have provided informed consent.
Random allocation procedure
Randomization to the active program or the comparator
will be on a 1:1 ratio and based on blocks of length 4,
stratified by sex and severity/extent of suicidal thoughts.
The latter is defined as endorsing ‘yes’ on item 5 of the
‘Suicidal Ideation’ part of the Columbia-Suicide Severity
Rating Scale (C-SSRS) [23], regarding active suicidal idea-
tion with specific plan and intent. The randomization pro-
cedure is incorporated into the website and therefore fully
automated. Participants are blinded as to which program
is active and which is control. Participants in the control
condition will receive access to the LWDT program after
the 12-month follow-up assessment.
Active condition: ‘Living with Deadly Thoughts’
Background
It has been convincingly demonstrated that online self-
help interventions reduce mental health problems [24-29].
Self-help is nowadays often offered through the Internet
Figure 1 Flow chart for the healthy thinking study.
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self-help generally shows larger effect sizes [24] and lower
dropout rates, whereas unguided self-help has the advan-
tage that it can be delivered to a large number of people at
relatively low cost.
There is a large body of research indicating that Cogni-
tive Behavior Therapy (CBT) is effective for many differentmental health problems [30], and most of the existing
(effective) self-help interventions are based on CBT [31].
The program used in this trial is called Living with Deadly
Thoughts and is a translation and adaptation of the Dutch
web-based program ‘Leven onder Controle’ (literally ‘Living
Under Control’). Its basis lies in evidence-based treat-
ment programs for suicidality, mainly Cognitive Behavior
Table 1 Items from the World Health Organization Trial
Registration Data Set
Data category Information
Primary registry and trial
identifying number
Australian New Zealand Clinical Trials
Registry: ACTRN12613000410752
Date of registration in
primary registry
15 April 2013
Secondary identifying
numbers
National Health and Medical Research
Council project grant: GNT1046317
Universal Trial Number: U1111-1141-6595
Source(s) of monetary or
material support
National Health and Medical Research
Council
Primary sponsor
Secondary sponsor(s)
Contact for public queries B.A.J. van Spijker
Contact for scientific
queries
B.A.J. van Spijker
Public title Healthy Thinking project: A randomized
controlled trial of a web-based self-help
program to reduce suicide ideation
Scientific title A randomized controlled trial comparing a
web-based self-help program to reduce
suicide ideation with an attention matched
control program in community members
with suicide ideation
Countries of recruitment Australia
Health condition(s) or
problem(s) studied
Suicidal thoughts
Intervention(s) Active comparator: ‘Living with Deadly
Thoughts’ program
Control comparator: ‘Living Well’ program
Key inclusion and
exclusion criteria
Ages eligible for study: 18 to 65 years;
Sexes eligible for study: both; Accepts
healthy volunteers: no
Inclusion criteria: current suicidal thoughts
Exclusion criteria: no current suicidal
thoughts; suicide attempt in the past
month; diagnosis of a psychotic disorder
Study type Interventional
Allocation: randomized; Intervention model:
parallel assignment; Masking: participants
blinded
Primary purpose: prevention
Date of first enrollment 19 November 2013
Target sample size 570
Recruitment status Recruiting
Primary outcome Suicidal thoughts
Key secondary outcomes Depression, hopelessness, reasons for living,
anxiety, panic, alcohol use, insomnia,
rumination, thwarted belongingness,
perceived burdensomeness, acquired
capability, health and disability, health care
utilization, health status, help seeking,
evaluation and utility of website
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(DBT); [34-37], but also Problem Solving Treatment
(PST); [38,39] and Mindfulness Based Cognitive Therapy
(MBCT); [40-42].
The main goal of the program is helping participants
decrease the frequency and intensity of their suicidal
thoughts. Special attention is given to the often repeti-
tive character of suicidal thoughts [43]. As such, these
thoughts are believed to be amenable to techniques
found to be effective in reducing worry thoughts used in
‘Metacognitive Therapy for Worry and Generalised Anx-
iety Disorder’ [44]. From a patient perspective, these
techniques are easy to grasp, offer novelty to those who
have had prior CBT treatment, and can be readily taught
as part of self-help care.
Structure
The program consists of six modules, and participants
are encouraged to complete one module per week.
Ideally, they spend 30 minutes per day on the program.
Each module contains four components: 1) theory, 2) a
weekly assignment, 3) two to three recommended exer-
cises, and 4) several optional exercises to help consoli-
date relevant information and skills. In addition, at the
end of each module a number of Frequently Asked
Questions (FAQs) are listed that participants can refer
to at any time. Each module builds on previous modules
and these become available in sequence, 4 days after
starting the previous module. Completed modules re-
main available throughout the intervention. Finally, par-
ticipants also have access to referral information via a
‘get-help-now’ button that is visible from every page.
Participants are also informed that participation is not
meant to replace treatment as usual and are therefore
encouraged to seek further treatment (if they are not re-
ceiving this already).
Content
In the first module, similarities between suicidal thinking
and worry are outlined. Core exercises are aimed at rec-
ognizing how often suicidal thoughts are repeated and
learning to manage this repetitiveness better. The second
module focuses on learning to tolerate and regulate in-
tense emotions. The theory section explains how to
recognize an upcoming crisis and taps into dealing with
the urge to self-harm. Core exercises introduce different
ways of coping with intense emotions, such as behavioral
activation (for example, seeking distraction), and accept-
ance (waiting until the feelings subside). Participants
are also encouraged to make a crisis plan. The third,
fourth, and fifth modules deal with identifying automatic
thoughts, recognizing common thinking patterns (for
example, all or nothing thinking, overgeneralization, and
mind reading), and cognitively restructuring the three
Table 2 Scales administered per measurement occasion
in the healthy thinking study
Measure Baseline 2 and
4 weeks
Post-test 6-month
follow-up
12-month
follow-up
Demographics X
C-SSRS X X (3
items)
X X X
SIDAS X X X X
Brief COPE X X X X
BRFL X X X X
CES-D X X X X
Hopelessness
scale
X X X X
GAD-7 X X X X
RRS X X X X
Brief PHQ
(panic subscale)
X X X X
INQ X X X X
ACSS X X X X
AUDIT-C X X X X
ISI X X X X
IEUQ X
GHSQ X
CSRI X X X X
SF-12 X X X X
WHODAS 2.0 X X X X
C-SSRS, Columbia Suicide Severity Rating Scale; SIDAS, Suicidal Ideation Attributes
Scale; Brief COPE, Brief Coping Orientation Problems Experienced; BRFL, Brief
Reasons for Living Scale; CES-D, Center for Epidemiological Studies - Depression;
GAD-7, Generalized Anxiety Disorder-7; RRS, Ruminative Response Scale; Brief
PHQ, Brief Patient Health Questionnaire; INQ, Interpersonal Needs Questionnaire;
ACSS, Acquired Capability for Suicide Scale; AUDIT-C, Alcohol Use Disorders
Identification Test Consumption; ISI, Insomnia Severity Index; IEUQ, Internet
Evaluation and Utility Questionnaire; GHSQ, General Help-Seeking Questionnaires;
CSRI, Client Service Receipt Inventory; SF-12, Short Form-12; WHODAS 2.0, World
Health Organization Disability Assessment Schedule 2.0.
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The final module is dedicated to relapse prevention. It
discusses the possibility of future setbacks and disap-
pointments. Core exercises pertain to envisaging a realis-
tic picture of the future, dealing with future setbacks,
and recognizing and preventing relapse by making a re-
lapse prevention plan.
Attention-matched control condition: ‘Living Well’
The attention-matched control condition uses a 6-week
program that contains lifestyle information. This pro-
gram follows a similar structure to the active program;
that is, each module contains theory, a weekly assign-
ment, several exercises, and a number of FAQs. Each
module has a different topic: 1) nutrition, 2) a healthy
home environment, 3) a healthy weight, 4) a healthy
heart, 5) a healthy skin, and 6) a healthy mouth. The
program was designed so that no specific mental health
information or suicide-related content was included.
New modules become available 4 days after starting the
previous module. Similar to the active program, partici-
pants in the Living Well program have access to referral
information via a ‘get-help-now’ button that is visible
from every page and are informed that participation is
not meant to replace treatment they may already be re-
ceiving or the necessity to seek further treatment.
Measures
Primary outcome measure
The primary outcome measure is severity of suicidal
thoughts, assessed using the ‘intensity of suicidal idea-
tion’ section of the C-SSRS [23]. The C-SSRS was devel-
oped to identify those at risk and track changes in a
person’s suicidal thinking and behavior over time. The
full scale addresses the complete range of suicidal think-
ing and behavior and consists of three parts: 1) suicidal
ideation, 2) intensity of suicidal ideation, and 3) suicidal
behavior. Table 2 provides an overview of all measures
used in the study.
Secondary outcome measures
Secondary outcome measures include the following:
reporting of suicide plans, measured by the ‘suicidal
ideation’ section of the C-SSRS; capacity to cope with
suicidal thoughts, using selected scales (self-distraction,
active coping, positive reframing, planning, and self-
blame) from the Brief Coping Orientation Problems Ex-
perienced (Brief COPE) [45]; reasons for living, using
the Brief Reasons for Living Scale (BRFL) [46]; symp-
toms of depression, measured by Centre for Epidemio-
logical Studies - Depression (CES-D) [47]; hopelessness,
assessed by the Burns Hopelessness Scale (unpublished
scale, Burns, D.D.); anxiety/worry, measured by the Gen-
eralized Anxiety Disorder-7 (GAD-7) [48]; rumination,assessed by the Ruminative Response Scale (RSS) [49,50];
panic, using the panic syndrome subscale of the Brief Pa-
tient Health Questionnaire (Brief PHQ) [51,52]; perceived
burdensomeness and thwarted belongingness, assessed by
the Interpersonal Needs Questionnaire (INQ) [53]; ac-
quired capability, measured by the Acquired Capability for
Suicide Scale (ACSS) [53]; alcohol consumption, using the
Alcohol Use Disorders Identification Test Consumption
(AUDIT-C) [54]; and insomnia, assessed by the Insomnia
Severity Index (ISI) [55,56].
In addition, the following measures will be included to
assess predictors of outcome and potential mediators of
the effectiveness of the program: standard demographic
information including internet literacy; history of sui-
cidal thoughts, measured by number of months having
experienced suicidal thoughts; history of suicide at-
tempts, assessed by self-reported lifetime suicide attempts;
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evaluation of the program, using the Internet Evaluation
and Utility Questionnaire (IEUQ) [57,58] and several add-
itional questions; and help-seeking for suicidal thoughts,
assessed by the General Help-Seeking Questionnaires
(GHSQ) [59].
Finally, a recently developed scale, the Suicidal Idea-
tion Attributes Scale (SIDAS) [60], is included in the
study to further validate it in a help-seeking population
and determine sensitivity to change. See also Table 1.Cost-effectiveness
In addition to the outcomes described above, several
measures are included in the study to allow for cost-
effectiveness analyses. Specifically, the Client Service Re-
ceipt Inventory (CSRI) is used to collect data on health
care utilization [61]. The CSRI can be tailored to suit
data requirements, and in the current study the follow-
ing domains will be captured: GP consultations, practice
nurse visits, use of hospital services for physical prob-
lems, use of hospital services for mental health prob-
lems, mental health helpline contacts, psychiatric crisis
support team contacts, social worker contacts, counsel-
ing contacts, therapy contacts, self-help group contacts,
and psychiatrist contacts. In addition, the Short Form-12
(SF-12) [62] is included as a generic measure of per-
ceived health status that can be used to estimate a
preference-based single index for use in economic evalu-
ations [63]. Similarly, the World Health Organization
Disability Assessment Schedule 2.0 (WHODAS 2.0) is
administered to assess generic health and disability
[64,65]. Finally, costs related to the program are docu-
mented. See also Table 1.Safety of participants
As this research is being conducted in a vulnerable, at-
risk population, safety procedures were designed in col-
laboration with the Suicide Call Back Service (SCBS),
which is an Australia-wide 24-hour service that provides
telephone and online counseling to people 15 years and
over who are suicidal, are bereaved by suicide, have a
suicidal loved one, or are professionals working with sui-
cidal clients. The goal was to design a procedure that
would protect and assist participants while enabling
them to maintain anonymity within the trial if they
chose.
To be able to enroll in the study, eligible participants
will be required to contact the SCBS to obtain a unique
code. They will be required to submit this code on their
first login to the trial portal, before the participant is di-
rected to the baseline questionnaire. This code subse-
quently enables researchers to identify the participant tothe SCBS when needed (and vice versa), while not re-
vealing the identity of the individual.
On each measurement occasion (that is, 2 and 4 weeks
into the program, the week 6 post-test, 6-month follow-
up and 12-month follow-up), the first three items of the
‘intensity of ideation’ section of the C-SSRS are used to
detect high risk, defined as a score of 5 on any of these
items. Whenever a participant meets this criterion, an
automated email will prompt them to contact the SCBS.
If they do not contact the SCBS within 2 days, an auto-
mated reminder will be sent. At the same time of this re-
minder, an automated email will be sent to the SCBS,
which will contain the participant’s contact details if
these were provided at registration. If no contact details
were provided, the SCBS will take no further action;
otherwise the SCBS will try to call the participant with a
maximum of three attempts.
These safety procedures were designed from the per-
spective that participants should be able to maintain
their anonymity as much as possible considering ethical
and clinical obligations and also should be allowed to
remain autonomous in their decision to make contact
with services as much as possible. This approach is
consistent with the concept of self-help and patient
empowerment.Sample size and power
Power to detect change in suicidal thoughts is based on
the expected effect of the intervention on the primary
outcome measure. Based on the findings from the Dutch
trial [18], the expected effect size is 0.30 (Cohen’s d). To
be able to detect this effect size, assuming a correlation
between pre- and post-test measures of .5, including an
expected drop-out rate of 30%, and allowing a width of
about ± 0.20 for the confidence intervals of the effect
size, 285 starters (expected to yield 200 completers)
would be needed in each condition (with alpha = 0.05
and power of 0.80). The aim is therefore to recruit 570
participants in the trial.Statistical considerations
Primary analyses will be undertaken on an intention-to-
treat basis, including all participants randomized regard-
less of their level of adherence to the program or trial
drop-out (unless someone specifically requests to remove
their data from the study). Available information from all
participants will be retained using linear mixed models
analyses. Transformation of variables will be done as
necessary to meet distributional assumptions and to ac-
commodate potential outlying observations. For other
analyses, multiple imputation including demographic and
other background variables will be used as necessary to
allow inclusion of data from all participants.
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A Data Safety Monitoring Board (DSMB) has been estab-
lished for this study, consisting of two senior psychiatrists
and one senior suicidologist. All members have extensive
clinical and/or research experience with suicidal people.
This DSMB is independent of all investigators and the
funding agency, and no member of the DSMB has direct
involvement in the conduct of the study. The DSMB will
receive monthly reports from the trial manager detailing
the number of participants contacting the SCBS and
number of self-reported suicide attempts on completed
follow-up questionnaires. Furthermore, the DSMB will
be notified of any adverse events within 72 hours of
knowledge of the event. The DSMB will also receive a
report if there is any evidence suggesting potential risk
to participants, for example, as detected by the trial
manager or chief investigators. Finally, interim analyses
will be performed once one-third of the total sample
(that is, 190 participants) has reached 1) the 6-week
post-test assessment, 2) the 6-month follow-up, and 3)
the 12-month follow-up. The DSMB may recommend
termination or modification of the study on the basis of
any perceived safety concern based on their clinical
judgment. This may include, but is not limited to,
higher anticipated rates of primary safety indicators
(suicidal ideation and attempted suicide, both assessed
by self-report), or unexpected serious adverse events.
Ethics approval, data storage, and dissemination of
results
This study (protocol version 2, 17 June 2013) has been
approved by the Human Research Ethics Committees of
the University of New South Wales (#HC13117) and the
Australian National University (2013/416). Any modifi-
cations to the protocol will be agreed upon by the re-
searchers and approved by the ethics committees prior
to implementation. Participant responses will be identi-
fied by a unique user ID. Data files linking email ad-
dresses to ID numbers will be stored separately from
raw research data. Collected data will be stored on a se-
cure server. All chief investigators will be given access to
the data set, and data will be published in nonidentifi-
able form. Authorship will be based on contribution to
the study. A de-identified data set will be available from
the authors no later than 3 years after collection of the
final post-test data.
Discussion
This paper describes the study protocol of a randomized
controlled trial comparing a web-based self-help pro-
gram for suicidal thoughts with an attention-matched
program. This trial is a continuation of the first study
that examined the effectiveness of web-based self-help
for suicidal thoughts in the Netherlands [17-19] and isthe first English-language RCT of this sort. The use of
an attention-matched comparator condition, increased
levels of participant anonymity, longer follow-up pe-
riods, and an improved look and feel of the program
website improved the design of the study.
This study will contribute to the growing body of evi-
dence regarding the effectiveness of online suicide pre-
vention. Currently, there is evidence indicating that a
reduction in suicidal thoughts is associated with the use
of web-interventions [15,16], and that the effect is
greater than waitlist control condition [18]; but more re-
search is needed to establish that programs targeting sui-
cidal thoughts are more effective than wait lists. If
effective, web-based self-help has the potential to be im-
plemented and disseminated in a cost-effective way
[17,66-68].
Limitations of this study include the potential for high
drop-out, to which web-based self-help programs are
often subject [69,70] and may introduce selection bias.
The anonymity of the participants will make it impos-
sible to ascertain whether any suicides occur during the
study. Similarly, the recording of suicide attempts relies
solely on self-report and cannot be verified by objective
records. Both these limitations are inherent to the self-
help character of the trial and mimic real-life conditions
if the program were to be implemented after the trial.
Trial status
Recruitment started in November 2013 and is due to
finish in 2015. The final participants are expected to
complete their 12 month follow-up assessment in 2016.
Additional files
Additional file 1: Participant information statement.
Additional file 2: Consent form.
Abbreviations
ACSS: Acquired Capability for Suicide Scale; AUDIT-C: Alcohol Use Disorders
Identification Test Consumption; Brief COPE: Brief Coping Orientation
Problems Experienced; Brief PHQ: Brief Patient Health Questionnaire;
BRFL: Brief Reasons for Living Scale; CBT: Cognitive Behavior Therapy;
CES-D: Center for Epidemiological Studies - Depression; CSRI: Client Service
Receipt Inventory; C-SSRS: Columbia-Suicide Severity Rating Scale;
DBT: Dialectical Behavior Therapy; DSMB: Data Safety Monitoring Board;
FAQs: frequently asked questions; GAD-7: Generalized Anxiety Disorder-7;
GHSQ: General Help-Seeking Questionnaire; IEUQ: Internet Evaluation and
Utility Questionnaire; INQ: Interpersonal Needs Questionnaire; ISI: Insomnia
Severity Index; LWDT: Living with Deadly Thoughts; MBCT: Mindfulness
Based Cognitive Therapy; PST: Problem Solving Treatment; RCT: randomized
controlled trial; RRS: Ruminative Response Scale; SCBS: Suicide Call Back
Service; SF-12: Short Form-12; SIDAS: Suicidal Ideation Attributes
Scale; WHODAS 2.0: World Health Organization Disability Assessment
Schedule 2.0.
Competing interests
BvS and AK are authors of the Dutch web-based program described in this
manuscript. BvS and AK are also authors of, and receive royalties from, an
adapted paper version of the self-help program, published under the title
van Spijker et al. Trials  (2015) 16:62 Page 9 of 10‘Piekeren over zelfdoding’ by Boom: Amsterdam (2012). BvS, AK and HC are
authors of the English translation of the web-based program described in
this manuscript.
Authors’ contributions
BvS and AK conducted the study in the Netherlands on which the current
project is based. BvS, AC, PB, AM, JG, AK and HC obtained funding for the
Australian study. DS is trial manager for the study. All authors contributed to
the design of this study, the writing of the manuscript, and have read and
approved the final version of the manuscript.
Acknowledgements
This study is supported by a grant from the National Health and Medical
Research Council (NHMRC) Australia (GNT1046317) and forms part of
research conducted by the NHMRC Centre for Research Excellence in Suicide
Prevention (CRESP) (GNT1042580). The funder does not have any role or
ultimate authority in the study design; collection, management, analysis, and
interpretation of data; writing of the report; and the decision to submit the
report for publication. AC is supported by NHMRC Early Career Fellowship
1013199. PB is supported by NHMRC Early Career Fellowship 1035262. HC is
supported by NHMRC Fellowship 1056964.
Author details
1National Institute for Mental Health Research, The Australian National
University, Building 63, Canberra, ACT 2601, Australia. 2Black Dog Institute,
The University of New South Wales, Hospital Road, Prince of Wales Hospital,
Randwick, NSW 2031, Australia. 3Orygen Youth Health Research Centre,
University of Melbourne, 35 Poplar Road, Parkville, VIC 3052, Australia.
4Department of Clinical Psychology and the EMGO Institute for Health and
Care Research, Faculty of Psychology and Education, VU University
Amsterdam, van der Boechorststraat 1, 1081 BT Amsterdam, the Netherlands.
Received: 19 August 2014 Accepted: 3 February 2015
References
1. Nock MK, Borges G, Bromet EJ, Alonso J, Angermeyer M, Beautrais A, et al.
Cross-national prevalence and risk factors for suicidal ideation, plans and
attempts. Br J Psychiatry. 2008;192:98–105.
2. Johnston AK, Pirkis JE, Burgess PM. Suicidal thoughts and behaviours
among Australian adults: findings from the, National Survey of Mental
Health and Wellbeing. Aust N Z J Psychiatry. 2009;43:635–43.
3. Bruffaerts R, Demytenaere K, Hwang I, Chiu WT, Sampson N, Kessler RC,
et al. Treatment of suicidal people around the world. Br J Psychiatry.
2011;199:64–70.
4. Rickwood D, Deane FP, Wilson CJ, Ciarrochi J. Young people's help-seeking
for mental health problems. AeJAMH. 2005;4 Suppl 3:1–34.
5. Gould MS, Munfakh JLH, Kleinman M, Lake AM. National suicide prevention
lifeline: Enhancing mental health care for suicidal individuals and other
people in crisis. Suicide Life Threat Behav. 2012;42:22–35.
6. Michelmore L, Hindley P. Help-seeking for suicidal thoughts and self-harm
in young people: A systematic review. Suicide Life Threat Behav.
2012;42:507–24.
7. Gould MS, Kalafat J. Crisis hotlines. In: Wasserman D, Wasserman C, editors.
Suicide and Suicide Prevention. Oxford: Oxford University Press; 2009. p. 459–62.
8. Mokkenstorm J, Huisman A, Kerkhof AJFM. Suicide prevention via internet
and telephone: 113Online [in Dutch]. Tijdschr Psychiatr. 2012;54:341–8.
9. Barak A. Emotional support and suicide prevention through the internet:
A field project report. Comput Human Behav. 2007;23:971–84.
10. Haas A, Koestner B, Rosenberg J, Moore D, Garlow SJ, Sedway J, et al. An
interactive web-based method of outreach to college students at risk for
suicide. J Am Coll Health. 2008;57:15–22.
11. Harris KM, McLean JP, Sheffield J. Examining suicide-risk individuals who go
online for suicide-related purposes. Arch Suicide Res. 2009;13:264–76.
12. Krysinska KE, De Leo D. Telecommunication and suicide prevention: hopes
and challenges for the new century. Omega. 2007;55:237–53.
13. Pietrzak E, McLaughlin R. The effectiveness of online suicide prevention
programs: 1998-2009. A literature review. Brisbane: University of Queensland
- Centre for Military and Veterans Health; 2009.
14. Lai MH, Maniam T, Chan LF, Ravidran AV. Caught in the web: A review of
web-based suicide prevention. JMIR. 2014;16:e30.15. Watts S, Newby JM, Mewton L, Andrews G. A clinical audit of changes in
suicide ideas with internet treatment for depression. BMJ Open.
2012;2:e001558.
16. Christensen H, Farrer L, Batterham PJ, Mackinnon A, Griffiths KM, Donker T.
The effect of a web-based depression intervention on suicide ideation:
secondary outcome from a randomised controlled trial in a helpline. BMJ
Open. 2013;3:e002886.
17. van Spijker BAJ, Majo CM, Smit F, van Straten A, Kerkhof AJFM. Reducing
suicidal ideation: Cost-effectiveness analysis of a randomized controlled trial
of unguided web-based self-help. JMIR. 2012;14:e141.
18. van Spijker BAJ, van Straten A, Kerkhof AJFM. Effectiveness of online
self-help for suicidal thoughts: Results of a randomised controlled trial.
PLoS One. 2014;9:e90118.
19. van Spijker BAJ, van Straten A, Kerkhof AJFM. The effectiveness of a web-
based self-help intervention to reduce suicidal thoughts: A randomized
controlled trial. Trials. 2010;11:25.
20. van Orden KA, Witte TK, Cukrowicz KC, Braithwaite SR, Selby EA, Joiner TE.
The interpersonal theory of suicide. Psychol Rev. 2010;117:575–600.
21. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K,
et al. SPIRIT, Statement: Defining standard protocol items for clinical trials.
Ann Intern Med. 2013;158:200–7.
22. Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al.
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical
trials. BMJ. 2013;346:e7586.
23. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al.
The Columbia-Suicide Severity Rating Scale: Initial validity and internal
consistency findings from three multisite studies with adolescents and
adults. Am J Psychiatry. 2011;168:1266–77.
24. Andersson G, Cuijpers P. Internet-based and other computerized
psychological treatments for adult depression: A meta-analysis. Cogn Behav
Ther. 2009;38:196–205.
25. Andrews G, Cuijpers P, Craske MG, McEnvoy P, Titov N. Computer therapy
for the anxiety and depression disorders is effective, acceptable and
practical health care: A meta-analysis. PLoS One. 2010;5:e13196.
26. Cuijpers P, van Straten A, Andersson G. Internet-administered cognitive behavior
therapy for health problems: a systematic review. J Behav Med. 2008;31:169–77.
27. Gainsbury S, Blaszczynski A. A systematic review of internet-based therapy
for the treatment of addictions. Clin Psychol Rev. 2011;31:490–8.
28. White A, Kavanagh D, Stallman H, Klein B, Kay-Lambkin F, Proudfoot J, et al.
Online alcohol interventions: A systematic review. JMIR. 2010;12:e62.
29. Griffiths KM, Farrer L, Christensen H. The efficacy of internet interventions for
depression and anxiety disorders: a review of randomised controlled trials.
MJA. 2010;192:S4–11.
30. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of
cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev.
2006;26:17–31.
31. Carlbring P, Andersson G. Internet and psychological treatment. How well
can they be combined? Comput Human Behav. 2006;22:545–53.
32. Tarrier N, Taylor K, Gooding P. Cognitive-behavioral interventions to reduce
suicide behavior. A systematic review and meta-analysis. Behav Modif.
2008;32:77–108.
33. Wenzel A, Brown GK, Beck AT. Cognitive therapy for suicidal patients:
Scientific and clinical applications. Washington, DC: American Psychological
Association; 2009.
34. Linehan MM. Cognitive-Behavioral Treatment of Borderline Personality
Disorder. New York, NY: Guilford Press; 1993.
35. Linehan MM. Skills Training Manual for Treating Borderline Personality
Disorder. New York, NY: Guilford Press; 1993.
36. van den Bosch LMC, Koeter MWJ, Stijnen T, Verheul R, van den Brink W.
Sustained efficacy of dialectical behaviour therapy for borderline personality
disorder. Behav Res Ther. 2005;43:1231–41.
37. Verheul R, van den Bosch LMC, Koeter MWJ, de Ridder MAJ, Stijnen T, van
den Brink W. Dialectical behaviour therapy for women with borderline
personality disorder. Br J Psychiatry. 2003;182:135–40.
38. Hawton K, Townsend E, Arensman E, Gunnell D, Hazell P, House A, et al.
Psychosocial and pharmacological treatments for deliberate self-harm
(review). Cochrane Database Syst Rev. 2000;2:CD001764.
39. Townsend E, Hawton K, Altman DG, Arensman E, Gunnell D, Hazell P, et al.
The efficacy of problem-solving treatments after deliberate self-harm:
meta-analysis of randomized controlled trials with respect to depression,
hopelessness and improvement in problems. Psychol Med. 2001;31:979–88.
van Spijker et al. Trials  (2015) 16:62 Page 10 of 1040. Barnhofer T, Crane C, Hargus E, Amarasinghe M, Winder R, Williams JMG.
Mindfulness-based cognitive therapy as a treatment for chronic depression:
A preliminary study. Behav Res Ther. 2009;47:366–73.
41. Williams JMG, Duggan D, Crane C, Fennell MJV. Mindfulness-based cognitive
therapy for prevention of recurrence of suicidal behavior. J Clin Psychol.
2006;62:201–10.
42. Williams JMG, Swales M. The use of mindfulness-based approaches for
suicidal patients. Arch Suicide Res. 2004;8:315–29.
43. Kerkhof AJFM, Van Spijker BAJ. Worrying and rumination as proximal risk
factors for suicidal behaviour. In: O'Connor RC, Platt S, Gordon J, editors.
International Handboook of Suicide Prevention: Research, Policy and
Practice. Chichester: Wiley - Blackwell; 2011. p. 199–209.
44. Wells A. Metacognitive therapy for worry and generalised anxiety disorder.
In: Davey GCL, Wells A, editors. Worry and its psychological disorders:
Theory, Assessment and Treatment. Chichester: John Wiley & Sons, Ltd;
2006. p. 259–72.
45. Carver CS. You want to measure coping but your protocol's too long:
consider the brief COPE. Int J Behav Med. 1997;4:92–100.
46. Osman A, Kopper BA, Barrios FX, Osman JR, Besett T, Linehan MM. The brief
reasons for living inventory for adolescents (BRFL-A). J Abnorm Child
Psychol. 1996;24:433–43.
47. Sawyer RL. The CES-D scale: a self-report depression scale for research in
the general population. Appl Psychol Meas. 1977;1:385–401.
48. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing
generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7.
49. Treynor W, Gonzalez S, Nolen-Hoeksema S. Rumination reconsidered:
A psychometric analysis. Cognit Ther Res. 2003;26:167–77.
50. Nolen-Hoeksema S, Morrow J. A prospective study of depression and
posttraumatic stress symptoms after a natural disaster: The, Loma Prieta
earthquake. J Pers Soc Psychol. 1991;61:115–21.
51. Spitzer RL, Williams JBW, Kroenke K. Instructions for Patient Health
Questionnaire (PHQ) and GAD-7 measures. http://www.phqscreeners.com/
overview.aspx n.d. Accessed 14 August 2014.
52. Spitzer RL, Kroenke K, Williams JB. Validity and utility of a self-report version
of PRIME-MD. The PHQ primary care study. JAMA. 1999;282:1737–44.
53. van Orden KA, Witte TK, Gordon KH, Bender TW, Joiner TE. Suicidal desire
and the capability for suicide: Test of the interpersonal-psychological theory
of suicidal behavior among adults. J Consult Clin Psychol. 2008;76:72–83.
54. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol
consumption questions (AUDIT-C). Arch Intern Med. 1998;158:1789–95.
55. Bastien CH, Vallières A, Morin CM. Validation of the Insomnis Severity Index
as an outcome measure for insomnia research. Sleep Med. 2001;2:297–307.
56. Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index:
Psychometric indicators to detect insomnia cases and evaluate treatment
response. Sleep. 2011;34:601–8.
57. Ritterband LM, Ardalan K, Thorndike FP, Magee JC, Saylor DK, Cox DJ, et al.
Real world use of an Internet intervention for pediatric encopresis. J Med
Internet Res. 2008;10:e16.
58. Thorndike FP, Saylor DK, Bailey ET, Gonder-Frederick LA, Morin CM,
Ritterband LM. Development and perceived utility and impact of an Internet
intervention for insomnia. E J Appl Psychol. 2008;4:32–42.
59. Wilson CJ, Deane FP, Ciarrochi J. Measuring help-seeking intentions: Properties
of the General Help-Seeking Questionnaire. Can J Counsel. 2005;39:15–28.
60. van Spijker BAJ, Batterham PJ, Calear AL, Farrer L, Christensen H, Reynolds J,
et al. The Suicidal Ideation Attributes Scale (SIDAS): Community-based
validation study of a new scale for the measurement of suicidal ideation.
Suicide Life Threat Behav. 2014;44:408–19.
61. Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G,
Brewin CR, editors. Measuring mental health needs. London: Gaskell/Royal
College of Psychiatrists; 1992. p. 163–83.
62. Ware JE, Kolinski M, Keller SD. How to score the SF-12 physical and mental
health summaries: A user's manual. Boston, MA: The Health Institute, New
England Medical Centre; 1995.
63. Brazier JE, Robers J. The estimation of a preference-based measure of health
from the SF-12. Med Care. 2004;42:851–9.
64. Üstün TB, Kostansjsek N, Chatterji S, Rehm J. Measuring health and disability:
Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva:
World Health Organisation; 2010.
65. Ustun TB, Chatterji S, Kostansjsek N, Rehm J, Kennedy C, Epping-Jordan J.
Developing the World Health Organization Disability Assessment Schedule
2.0. Bull World Health Organ. 2010;88:815–23.66. Warmerdam L, Smit F, van Straten A, Riper H, Cuijpers P. Cost-utility and
cost-effectiveness of internet-based treatment for adults with depressive
symptoms: Randomized trial. J Med Internet Res. 2010;12:e53.
67. Gerhards SAH, de Graaf LE, Jacobs LE, Severens JL, Huibers MJH, Arntz A,
et al. Economic evaluation of online computerised cognitive-behavioural
therapy without support for depression in primary care: randomised trial.
Br J Psychiatry. 2010;196:310–8.
68. Cunningham JA, Khadjesari Z, Bewick BM, Riper H. Internet-based interventions
for problem drinkers: From efficacy trials to implementation. Drug Alcohol Rev.
2010;29:617–22.
69. Eysenbach G. The law of attrition. J Med Internet Res. 2005;7:e11.
70. Melville KM, Casey LM, Kavanagh DJ. Dropout from internet-based treatment
for psychological disorders. Br J Clin Psychol. 2010;49:455–71.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
